EraGen Antes Up in Anthrax-Detection Market With Own DNA-Based Product

Nov 07, 2001

NEW YORK, Nov. 7 - EraGen Biosciences on Wednesday threw its hat into the anthrax-detecting ring by announcing that it has developed a test that can detect the bacterium more rapidly than currently available tests.

The test, which is based on the company’s AEGIS technology, may help physicians reduce the time to detect the Bacillus anthracis “from days to hours,” EraGen said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

DNA Tests Considered to Verify Relatedness at Border

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

First of 'Right to Try'

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

This Week in Nature

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

How Old Were They?

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

Main menu